Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors ...

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

March is Colorectal Cancer Awareness Month.

This March, National Colorectal Cancer Awareness Month serves as a critical period for highlighting specific risk factors and the preventative measures necessary for long-term health ...

March is National Colorectal Cancer Awareness Month, a reminder that taking care of ourselves isn’t a weakness, but it’s a ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early warning system for the disease, ...

Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This method could be important for enhancing cervical ...

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...

Improving survival rates is dependent on early and accurate detection of breast cancer, which remains a major public health ...

Cervical cancer is a devastating reality for women in Uganda and throughout Sub-Saharan Africa, ranking as one of the leading causes of cancer-related deaths in the region. It represents ...